New hope for tough pancreatic cancer: targeted drug plus chemoradiation tested
NCT ID NCT07386704
First seen Feb 04, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This study tests a drug called nimotuzumab combined with radiation and chemotherapy for people with advanced pancreatic cancer that cannot be surgically removed. The goal is to see if this combination can better control the tumor locally for at least a year. The trial involves 30 participants and focuses on safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER NON-RESECTABLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Radiotherapy Oncology, Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Conditions
Explore the condition pages connected to this study.